{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:33Z","timestamp":1792068873591,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008109","name":"University of Notre Dame","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R37AI054193"],"award-info":[{"award-number":["5R37AI054193"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118805","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:29:34Z","timestamp":1789169374000},"page":"118805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An in vitro comparative study of cefiderocol, siderophore-aztreonam and siderophore-daptomycin conjugates against select gram-negative bacteria"],"prefix":"10.1016","volume":"143","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118805_bb0005","series-title":"2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","author":"WHO Bacterial Priority Pathogens List","year":"2024"},{"key":"10.1016\/j.bmc.2026.118805_bb0010","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.5c00570","article-title":"Multidrug-resistant Acinetobacter baumannii: a wily, existential threat to modern healthcare","author":"Maitra","year":"2025","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2026.118805_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive compound accumulation rules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2026.118805_bb0020","doi-asserted-by":"crossref","first-page":"26723","DOI":"10.1074\/jbc.270.45.26723","article-title":"Siderophores: structure and function of microbial iron transport compounds","volume":"270","author":"Neilands","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2026.118805_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1039\/b906679a","article-title":"Chemistry and biology of siderophores","volume":"27","author":"Hider","year":"2010","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmc.2026.118805_rf0030","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/acs.chemrev.0c01005","article-title":"Iron acquistion systems of gram-negative bacterial pathogens define tonb-dependent pathways to novel antibiotics","volume":"121","author":"Klebba","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bmc.2026.118805_rf0035","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00024-24","article-title":"Siderophore-mediated iron acquisition by Klebsiella pneumoniae","author":"Kumar","year":"2024","journal-title":"J. Bacteriology"},{"key":"10.1016\/j.bmc.2026.118805_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10534-008-9199-7","article-title":"Sideromycins: tools and antibiotics","volume":"22","author":"Braun","year":"2009","journal-title":"BioMetals"},{"issue":"94","key":"10.1016\/j.bmc.2026.118805_bb0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ange.19820940724","article-title":"Konstitution der Deferriform der Albomycine \u03b41, \u03b42 und \u03b5","volume":"1982","author":"Benz","year":"1982","journal-title":"Angew Chem"},{"key":"10.1016\/j.bmc.2026.118805_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hlca.19950780105","article-title":"Antibiotika aus Streptomycese violaceus, DSM 8286, mit siderophore-aminoglycosid-struktur","volume":"78","author":"V\u00e9rtesy","year":"1995","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.bmc.2026.118805_bb0050","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1021\/ja028386w","article-title":"Total synthesis of deferrisalmycin B","volume":"124","author":"Dong","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118805_bb0055","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bmj.2.4949.1177","article-title":"Recent studies on albomycin, a new antibiotic","volume":"2","author":"Gause","year":"1955","journal-title":"Br J Med"},{"key":"10.1016\/j.bmc.2026.118805_bb0060","first-page":"37","article-title":"Use of albomycin in pneumonia in children","volume":"5","author":"Gamburg","year":"1951","journal-title":"Pediatriia"},{"key":"10.1016\/j.bmc.2026.118805_bb0065","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijmm.2007.03.002","article-title":"Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae","volume":"297","author":"Pramanika","year":"2007","journal-title":"Intnl J Med Microbiol"},{"key":"10.1016\/j.bmc.2026.118805_bb0070","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1128\/JB.00205-06","volume":"188","author":"Pramanik","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmc.2026.118805_bb0075","first-page":"34","article-title":"Ferrimycin a, a new iron containing antibiotic","volume":"12","author":"Sackmann","year":"1962","journal-title":"Antibiot Chemother"},{"key":"10.1016\/j.bmc.2026.118805_rf0085","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/hlca.19600430730","article-title":"Stoffwechselprodukte von Actinomyceten. 25 mitteilung: \u00fcber die isolierung und charakterisierung der ferrimycine A1 und A2, neuer antibiotika der sideromycin-gruppe","volume":"43","author":"Bickel","year":"1960","journal-title":"Helv. Chim Acta"},{"key":"10.1016\/j.bmc.2026.118805_rf0090","first-page":"951","article-title":"Constitution of ferrimycin A1","volume":"5","author":"Bickel","year":"1965","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmc.2026.118805_bb0085","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1146\/annurev.micro.54.1.881","article-title":"Iron metabolism in pathogenic bacteria","volume":"54","author":"Ratledge","year":"2000","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.bmc.2026.118805_rf0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/ar00029a003","article-title":"Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates","volume":"26","author":"Miller","year":"1993","journal-title":"Accts. Chem. Res."},{"key":"10.1016\/j.bmc.2026.118805_rf0105","series-title":"Microbial iron chelates, Bergeron, R., ed., Chapter 13","first-page":"275","article-title":"Siderophore-mediated drug delivery: the design, synthesis and study of siderophore-antibiotic and antifungal conjugates","volume":"13","author":"Miller","year":"1994"},{"key":"10.1016\/j.bmc.2026.118805_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44259-024-00053-4","article-title":"Siderophores as tools and treatments","volume":"2","author":"Gr\u00e4ff","year":"2024","journal-title":"Npj Antimicrob Resist"},{"key":"10.1016\/j.bmc.2026.118805_bb0100","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/acs.accounts.1c00004","article-title":"Design and syntheses of new antibiotics inspired by nature's quest for iron in an oxidative climate","volume":"54","author":"Miller","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.bmc.2026.118805_bb0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1099\/00221287-144-7-1747","article-title":"The catecholate siderophores of Azotobacter vinelandii: their affinity for iron and role in oxygen stress management","volume":"144","author":"Cornish","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.bmc.2026.118805_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10534-009-9219-2","article-title":"Siderophores as drug delivery agents: application of the \u201cTrojan horse\u201d strategy","volume":"22","author":"M\u00f6llmann","year":"2009","journal-title":"Biometals"},{"key":"10.1016\/j.bmc.2026.118805_rf0130","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1021\/acs.jmedchem.7b01164","article-title":"Methodology for monobactam diversification: syntheses and studies of 4-thiomethyl substituted \u03b2-Lactams with activity against gram-negative bacteria, including carbapenemase producing Acinetobacter baumannii","volume":"60","author":"Carosso","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0135","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1021\/acsinfecdis.1c00458","article-title":"Conjugation of aztreonam, a synthetic monocyclic beta-lactam antibiotic, to a siderophore mimetic significantly expands activity against gram-negative bacteria","volume":"7","author":"Liu","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"56","key":"10.1016\/j.bmc.2026.118805_rf0140","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1021\/jm400265k","article-title":"Biscatecholate\u2013monohydroxamate mixed ligand siderophore\u2013carbacephalosporin conjugates are selective sideromycin antibiotics that target acinetobacter baumannii","volume":"2013","author":"Wencewicz","year":"2013","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/7355_2017_19","article-title":"Sideromycins as pathogen targeted antibiotics","volume":"26","author":"Wencewicz","year":"2017","journal-title":"Top. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10534-019-00192-6","article-title":"Synthetic sideromycins (skepticism and optimism): selective generation of either broad or narrow spectrum gram-negative antibiotics","volume":"32","author":"Lin","year":"2019","journal-title":"Biometals"},{"key":"10.1016\/j.bmc.2026.118805_rf0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ejmech.2018.06.014","article-title":"Cefiderocol, A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: structure activity relationship","volume":"155","author":"Aoki","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0160","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics"},{"issue":"71","key":"10.1016\/j.bmc.2026.118805_bb0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jac\/dkv402","article-title":"In vitro antimicrobial activity of S-649266, a catechol substituted siderophore cephalosporin, when tested against non-fermenting gram-negative bacteria","volume":"2016","author":"Ito","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2026.118805_bb0140","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","article-title":"Siderophore cephalosporin Cefiderocol utilizes ferric iron transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa","volume":"60","author":"Ito","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118805_bb0145","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/AAC.36.4.840","article-title":"Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore- carbacephalosporin conjugates","volume":"36","author":"Minnick","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"65","key":"10.1016\/j.bmc.2026.118805_bb0150","article-title":"New perspectives on antimicrobial agents: cefiderocol","volume":"2021","author":"McCreary","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118805_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41429-023-00687-y","article-title":"Cephalosporin resistance, tolerance, and approaches to improve their activities","volume":"77","author":"Araten","year":"2024","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmc.2026.118805_bb0160","article-title":"Siderophore cephalosporins","author":"Page","year":"2025","journal-title":"AntiMicrob ChemotherpEcoSal Plus"},{"key":"10.1016\/j.bmc.2026.118805_bb0165","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41429-024-00762-y","article-title":"In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol","volume":"77","author":"Kriz","year":"2024","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmc.2026.118805_bb0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10534-009-9218-3","article-title":"Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin \u201cTrojan horse\u201d antibiotics and synthetic desferridanoxamine-antibiotic conjugates","volume":"22","author":"Wencewicz","year":"2009","journal-title":"Biometals"},{"key":"10.1016\/j.bmc.2026.118805_bb0175","series-title":"Program and abstracts of the 25th interscience conference on antimicrobial agents and chemotherapy","first-page":"158","article-title":"Structure-activity relationships among sulfonylaminocarbonyl activated mono bactams leading to SQ-83,360","volume":"Vol. No 371","author":"Breuer","year":"1985"},{"key":"10.1016\/j.bmc.2026.118805_bb0180","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.7164\/antibiotics.43.1199","article-title":"Synthesis and structure-activity relationships of Monocarbams leading to U-78608","volume":"43","author":"Barbachyn","year":"1990","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmc.2026.118805_bb0185","doi-asserted-by":"crossref","first-page":"22002","DOI":"10.1073\/pnas.1013092107","article-title":"Structural basis for effectiveness of Siderophore-conjugated monocarbams against clinically relevant strains of pseudomonas","volume":"107","author":"Han","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2026.118805_bb0190","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1021\/ml200012f","article-title":"Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel Siderophore-conjugated Monocarbam Diols","volume":"2","author":"Flanagan","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118805_bb0195","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/AAC.01345-12","article-title":"Clinically relevant gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel Siderophore-conjugated Monocarbam","volume":"56","author":"McPherson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118805_bb0200","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/AAC.04172-14","article-title":"Potentiation of antibacterial activity of the MB-1 Siderophore- Monobactam conjugate using an efflux pump inhibitor","volume":"59","author":"Tomaras","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2291\u20132302","key":"10.1016\/j.bmc.2026.118805_bb0205","first-page":"7396","article-title":"In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram negative bacilli","volume":"54","author":"Page","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118805_rf0240","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00726-013-1468-2","article-title":"Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways","volume":"44","author":"Schalk","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmc.2026.118805_rf0245","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/jacs.8b01042","article-title":"Esterase-catalyzed siderophore hydrolysis activates an enterobactin\u2013ciprofloxacin conjugate and confers targeted antibacterial activity","volume":"140","author":"Neumann","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmc.2026.118805_bb0215","doi-asserted-by":"crossref","first-page":"21310","DOI":"10.1021\/jacs.0c06987","article-title":"Platform to discover protease-activated antibiotics and application to siderophore-antibiotic conjugates","volume":"142","author":"Boyce","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2026.118805_rf0255","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1021\/acs.jmedchem.8b00218","article-title":"A synthetic dual drug sideromycin induces gram-negative bacteria to commit suicide with a gram-positive antibiotic","volume":"61","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0260","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/acs.jmedchem.8b00522","article-title":"A trojan-horse strategy including a bacterial suicide action for the efficient use of a specific gram-positive antibiotic on gram-negative bacteria","volume":"61","author":"Schalk","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0265","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1021\/acs.jmedchem.7b00102","article-title":"Targeted antibiotic delivery: selective siderophore conjugation with daptomycin confers potent activity against multi-drug resistant Acinetobacter baumannii both in vitro and in vivo","volume":"60","author":"Ghosh","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2026.118805_rf0270","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acsinfecdis.8b00150","article-title":"Siderophore conjugates of daptomycin are potent inhibitors of carbapenem resistant strains of Acinetobacter baumannii","volume":"4","author":"Ghosh","year":"2018","journal-title":"ACS. Infect. Dis."},{"key":"10.1016\/j.bmc.2026.118805_bb0230","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41429-019-0268-7","article-title":"Antibiotic repurposing: Bis-catechol- and mixed ligand (Bis-catechol-mono-hydroxamate)-Teicoplanin conjugates are active against multi-drug resistant Acinetobacter baumannii","volume":"73","author":"Ghosh","year":"2020","journal-title":"J Antibiotics"},{"key":"10.1016\/j.bmc.2026.118805_bb0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/ml300150y","article-title":"Syntheses of Siderophore-drug conjugates using a convergent Thiol-Maleimide system","volume":"3","author":"Ju\u00e1rez-Hern\u00e1ndez","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118805_bb0240","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1039\/D2MD00465H","article-title":"Siderophore conjugates to combat antibiotic resistant bacteria","volume":"14","author":"Rayner","year":"2023","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2026.118805_bb0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.02005-12","article-title":"The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens","volume":"57","author":"Randall","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2026.118805_bb0250","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.tet.2011.11.065","article-title":"EDTA and DTPA modified ligands as sequestering agents for uranyl decorporation","volume":"68","author":"Leydier","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2026.118805_bb0255","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 8th ed. (Villanova, PA, USA)","year":"2009"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:36:40Z","timestamp":1792067800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":60,"alternative-id":["S0968089626002610"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118805","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro comparative study of cefiderocol, siderophore-aztreonam and siderophore-daptomycin conjugates against select gram-negative bacteria","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118805"}}